Wafik El-Deiry: Interesting presentation by Jakub Godlewski at the emerging brain tumor program
Wafik El-Deiry shared on X:
“Interesting invited presentation by Jakub Godlewski from Mossakowski Medical Research Center in Warsaw, Poland at Legorreta Cancer Center, Brown University emerging brain tumor program hosted by Sean Lawler.
Dr. Godlewski spoke about ‘Peptidome cargo of ex vivo modified brain cancer cell-derived extracellular vesicles boosts anti-tumor immune responses’.”
Source: Wafik El-Deiry/X
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21 (WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
